Anoctamin 6 (ANO6) (Middle Region) Peptide
-
- Target See all Anoctamin 6 (ANO6) products
- Anoctamin 6 (ANO6)
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- KSKGNPYSDL GNHTTCRYRD FRYPPGHPQE YKHNIYYWHV IAAKLAFIIV
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-TMEM16F Antibody(ARP44761_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Anoctamin 6 (ANO6)
- Background
-
TMEM16F may act as a calcium-activated chloride channel.
Alias Symbols: MGC104751, SCTS, BDPLT7, TMEM16F
Protein Size: 910 - Molecular Weight
- 106 kDa
- Gene ID
- 196527
- NCBI Accession
- NM_001025356, NP_001020527
- UniProt
- Q4KMQ2
-